Exact Mass: 383.3763

Exact Mass Matches: 383.3763

Found 54 metabolites which its exact mass value is equals to given mass value 383.3763, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Stearoyl Valine

3-Methyl-2-(octadecanoylamino)butanoic acid

C23H45NO3 (383.3399)


N-stearoyl valine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Stearic acid amide of Valine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Stearoyl Valine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Stearoyl Valine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   
   

(2S,3R,4E)-N-[acetoxy]-2-amino-4-henicosene-1,3-diol|tanacetamide B

(2S,3R,4E)-N-[acetoxy]-2-amino-4-henicosene-1,3-diol|tanacetamide B

C23H45NO3 (383.3399)


   

1,3-dihydroxy-2-hexanoylamino-(4E)-heptadecene

1,3-dihydroxy-2-hexanoylamino-(4E)-heptadecene

C23H45NO3 (383.3399)


   

(+)-serinolamide A|serinolamide A

(+)-serinolamide A|serinolamide A

C23H45NO3 (383.3399)


   

Dihydro-(E)-N-[3-[[4-(Dimethylamino)butyl]methylamino]propyl]-3-methyl-2-dodecenamide

Dihydro-(E)-N-[3-[[4-(Dimethylamino)butyl]methylamino]propyl]-3-methyl-2-dodecenamide

C23H49N3O (383.3875)


   
   

N-(2-Hydroxyethyl)docosanamide

N-(2-Hydroxyethyl)docosanamide

C24H49NO2 (383.3763)


   

Behenoyl-EA

N-(2-hydroxyethyl)-docosanamide

C24H49NO2 (383.3763)


   

N-stearoyl valine

N-octadecanoyl-valine

C23H45NO3 (383.3399)


   

NA 23:1;O2

N-octadecanoyl-valine

C23H45NO3 (383.3399)


   

NAE 22:0

N-(Docosanoyl)-ethanolamine

C24H49NO2 (383.3763)


   

2-(diethylamino)ethyl stearate

2-(diethylamino)ethyl stearate

C24H49NO2 (383.3763)


   

N-(2-aminoethyl)ethane-1,2-diamine,(9Z,12Z)-octadeca-9,12-dienoic acid

N-(2-aminoethyl)ethane-1,2-diamine,(9Z,12Z)-octadeca-9,12-dienoic acid

C22H45N3O2 (383.3512)


   

N-octadecanoyl-L-valine

N-octadecanoyl-L-valine

C23H45NO3 (383.3399)


   

Serinolamide A

Serinolamide A

C23H45NO3 (383.3399)


A natural product found in Lyngbya majuscula.

   

2-Hydroxytetracosanoate

2-Hydroxytetracosanoate

C24H47O3- (383.3525)


   

(2R,3S)-2-decyl-3-hydroxytetradecanoate

(2R,3S)-2-decyl-3-hydroxytetradecanoate

C24H47O3- (383.3525)


   
   

Omega-hydroxytetracosanoate

Omega-hydroxytetracosanoate

C24H47O3- (383.3525)


An omega-hydroxy fatty acid anion that is the conjugate base of omega-hydroxytetracosanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(R)-2-hydroxylignocerate

(R)-2-hydroxylignocerate

C24H47O3- (383.3525)


A hydroxy fatty acid anion that is the conjugate base of (R)-2-hydroxylignoceric acid, obtained by deprotonation of the carboxy group.

   

(E)-2-aminotetracos-4-ene-1,3-diol

(E)-2-aminotetracos-4-ene-1,3-diol

C24H49NO2 (383.3763)


   

(4E)-2-(Hexanoylamino)-4-heptadecene-1,3-diol

(4E)-2-(Hexanoylamino)-4-heptadecene-1,3-diol

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]heptanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]pentanamide

C23H45NO3 (383.3399)


   

(Z)-N-(1,3-dihydroxynonan-2-yl)tetradec-9-enamide

(Z)-N-(1,3-dihydroxynonan-2-yl)tetradec-9-enamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]pentadecanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]pentadecanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxyhenicos-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxyhenicos-4-en-2-yl]acetamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]octanamide

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]octanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]propanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]nonanamide

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]nonanamide

C23H45NO3 (383.3399)


   

(Z)-N-(1,3-dihydroxyoctan-2-yl)pentadec-9-enamide

(Z)-N-(1,3-dihydroxyoctan-2-yl)pentadec-9-enamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]tetradecanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]tetradecanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]butanamide

C23H45NO3 (383.3399)


   

(Z)-N-(1,3-dihydroxydecan-2-yl)tridec-9-enamide

(Z)-N-(1,3-dihydroxydecan-2-yl)tridec-9-enamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]undecanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]undecanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]tridecanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]tridecanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]dodecanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]dodecanamide

C23H45NO3 (383.3399)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]decanamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]decanamide

C23H45NO3 (383.3399)


   

N-octadecanoyl-valine

N-octadecanoyl-valine

C23H45NO3 (383.3399)


   

2-Hydroxylignocerate

2-Hydroxylignocerate

C24H47O3 (383.3525)


A 2-hydroxy fatty acid anion that is the conjugate base of 2-hydroxylignoceric (cerebronic) acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   
   
   
   
   

1,3-dihydroxy-2-hexanoylamino-(4e)-hepta-decene

NA

C23H45NO3 (383.3399)


{"Ingredient_id": "HBIN001179","Ingredient_name": "1,3-dihydroxy-2-hexanoylamino-(4e)-hepta-decene","Alias": "NA","Ingredient_formula": "C23H45NO3","Ingredient_Smile": "CCCCCCCCCCCCC=CC(C(CO)NC(=O)CCCCC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5903","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-[(2s,3s,4e)-1,3-dihydroxyheptadec-4-en-2-yl]hexanimidic acid

n-[(2s,3s,4e)-1,3-dihydroxyheptadec-4-en-2-yl]hexanimidic acid

C23H45NO3 (383.3399)


   

n-[(2r)-1-hydroxy-3-methoxypropan-2-yl]-n-methyloctadec-4-enamide

n-[(2r)-1-hydroxy-3-methoxypropan-2-yl]-n-methyloctadec-4-enamide

C23H45NO3 (383.3399)


   

n-(1,3-dihydroxyhenicos-4-en-2-yl)ethanimidic acid

n-(1,3-dihydroxyhenicos-4-en-2-yl)ethanimidic acid

C23H45NO3 (383.3399)


   

n-(1,3-dihydroxyheptadec-4-en-2-yl)hexanimidic acid

n-(1,3-dihydroxyheptadec-4-en-2-yl)hexanimidic acid

C23H45NO3 (383.3399)


   

(3s)-n-(3-{[4-(dimethylamino)butyl](methyl)amino}propyl)-3-methyldodecanimidic acid

(3s)-n-(3-{[4-(dimethylamino)butyl](methyl)amino}propyl)-3-methyldodecanimidic acid

C23H49N3O (383.3875)


   

n-(3-{[4-(dimethylamino)butyl](methyl)amino}propyl)-3-methyldodecanimidic acid

n-(3-{[4-(dimethylamino)butyl](methyl)amino}propyl)-3-methyldodecanimidic acid

C23H49N3O (383.3875)


   

n-[(2r,3s,4e)-1,3-dihydroxyhenicos-4-en-2-yl]ethanimidic acid

n-[(2r,3s,4e)-1,3-dihydroxyhenicos-4-en-2-yl]ethanimidic acid

C23H45NO3 (383.3399)